CXCL12 stimulation also induces resistance to chemo- and radiotherapy by maintaining and stimulating CXCR4-expressing adhesive cancer cells in a protective microenvironment like the bone marrow, as has been recently confirmed for hematological malignancies [239] and pancreatic cancer [241]. Here, CXCL12 is linked to cancer.